| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
CRW Overview
Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States.
Craneware Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£23.00 |
| 52 Week High | UK£15.00 |
| 52 Week Low | UK£28.30 |
| Beta | 1.06 |
| 1 Month Change | 0% |
| 3 Month Change | 4.55% |
| 1 Year Change | 48.39% |
| 3 Year Change | -18.58% |
| 5 Year Change | 86.61% |
| Change since IPO | 1,525.44% |
Recent News & Updates
Here's Why I Think Craneware (LON:CRW) Is An Interesting Stock
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Here's Why I Think Craneware (LON:CRW) Is An Interesting Stock
It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
Shareholder Returns
| CRW | GB Healthcare Services | GB Market | |
|---|---|---|---|
| 7D | -2.1% | -1.6% | 0.2% |
| 1Y | 48.4% | 42.0% | 24.7% |
Return vs Industry: CRW exceeded the UK Healthcare Services industry which returned 42.5% over the past year.
Return vs Market: CRW exceeded the UK Market which returned 23.2% over the past year.
Price Volatility
| CRW volatility | |
|---|---|
| CRW Beta | 1.06 |
| Industry Beta | 1.02 |
| Market Beta | 1 |
Stable Share Price: CRW is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: CRW's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 370 | Keith Neilson | https://public.craneware.com |
Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Chargemaster Toolkit, an automated software-as-a-service (SaaS) chargemaster management solution for capturing optimal legitimate reimbursement for providers; Trisus Supply, a solution that utilizes data to identify data gaps between the systems; Physician Revenue Toolkit, a SaaS solution for managing physician group KPIs, charges, codes, RVUs, fee schedules, and related information; Reference Plus, a SaaS solution to perform chargemaster analysis; Pharmacy ChargeLink, a solution to enhance charge capture, pricing, and cost management; integration for chargemaster management, a software that automatically uploads chargemaster changes to the patient billing system for accurate billing; Trisus Pricing Analyzer, a SaaS solution that simplifies the price modelling process; and Online Reference Toolkit and supplies assistant solutions. It also offers InSight Medical Necessity, a SaaS solution that provides medical necessity validation for the United States payors and advance beneficiary notice creation; Trisus Claims Informatics, a software that automates claim and coding reviews; and InSight Audit, a web-based audit management application for healthcare organizations to manage government and commercial audits.
Craneware Fundamentals Summary
| CRW fundamental statistics | |
|---|---|
| Market Cap | US$1.12b |
| Earnings (TTM) | US$12.91m |
| Revenue (TTM) | US$75.58m |
87.3x
P/E Ratio14.9x
P/S RatioIs CRW overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CRW income statement (TTM) | |
|---|---|
| Revenue | US$75.58m |
| Cost of Revenue | US$5.37m |
| Gross Profit | US$70.21m |
| Expenses | US$57.30m |
| Earnings | US$12.91m |
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.36 |
| Gross Margin | 92.89% |
| Net Profit Margin | 17.08% |
| Debt/Equity Ratio | 0% |
How did CRW perform over the long term?
See historical performance and comparisonDividends
1.2%
Current Dividend Yield79%
Payout RatioDoes CRW pay a reliable dividends?
See CRW dividend history and benchmarks| Craneware dividend dates | |
|---|---|
| Ex Dividend Date | Nov 25 2021 |
| Dividend Pay Date | Dec 21 2021 |
| Days until Ex dividend | 29 days |
| Days until Dividend pay date | 55 days |
Does CRW pay a reliable dividends?
See CRW dividend history and benchmarksValuation
Is Craneware undervalued compared to its fair value and its price relative to the market?
87.28x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: CRW (£22.9) is trading above our estimate of fair value (£7.4)
Significantly Below Fair Value: CRW is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: CRW is poor value based on its PE Ratio (86.8x) compared to the European Healthcare Services industry average (56.7x).
PE vs Market: CRW is poor value based on its PE Ratio (86.8x) compared to the UK market (21.3x).
Price to Earnings Growth Ratio
PEG Ratio: CRW is poor value based on its PEG Ratio (3.4x)
Price to Book Ratio
PB vs Industry: CRW's PB Ratio (4.3x) is in line with the GB Healthcare Services industry average.
Future Growth
How is Craneware forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
25.6%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CRW's forecast earnings growth (25.6% per year) is above the savings rate (0.9%).
Earnings vs Market: CRW's earnings (25.6% per year) are forecast to grow faster than the UK market (12.8% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: CRW's revenue (22% per year) is forecast to grow faster than the UK market (5% per year).
High Growth Revenue: CRW's revenue (22% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CRW's Return on Equity is forecast to be low in 3 years time (9.5%).
Past Performance
How has Craneware performed over the past 5 years?
5.9%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CRW has a large one-off loss of $6.5M impacting its June 30 2021 financial results.
Growing Profit Margin: CRW's current net profit margins (17.1%) are lower than last year (23.5%).
Past Earnings Growth Analysis
Earnings Trend: CRW's earnings have grown by 5.9% per year over the past 5 years.
Accelerating Growth: CRW's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: CRW had negative earnings growth (-23.3%) over the past year, making it difficult to compare to the Healthcare Services industry average (35.8%).
Return on Equity
High ROE: CRW's Return on Equity (5%) is considered low.
Financial Health
How is Craneware's financial position?
Financial Position Analysis
Short Term Liabilities: CRW's short term assets ($255.1M) exceed its short term liabilities ($49.4M).
Long Term Liabilities: CRW's short term assets ($255.1M) exceed its long term liabilities ($1.9M).
Debt to Equity History and Analysis
Debt Level: CRW is debt free.
Reducing Debt: CRW has not had any debt for past 5 years.
Debt Coverage: CRW has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: CRW has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Dividend
What is Craneware current dividend yield, its reliability and sustainability?
1.19%
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: CRW's dividend (1.2%) isn’t notable compared to the bottom 25% of dividend payers in the UK market (1.4%).
High Dividend: CRW's dividend (1.2%) is low compared to the top 25% of dividend payers in the UK market (4.06%).
Stability and Growth of Payments
Stable Dividend: CRW's dividends per share have been stable in the past 10 years.
Growing Dividend: CRW's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: At its current payout ratio (78.5%), CRW's payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: CRW's dividends in 3 years are forecast to be well covered by earnings (48.9% payout ratio).
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
10.8yrs
Average management tenure
CEO
Keith Neilson (52 yo)
22.75yrs
Tenure
US$465,535
Compensation
Mr. Keith Neilson co-founded Craneware PLC in 1999 and has served as its Chief Executive Officer ever since. Keith’s direction has helped Craneware to win multiple prestigious awards in such areas as inter...
CEO Compensation Analysis
Compensation vs Market: Keith's total compensation ($USD465.54K) is below average for companies of similar size in the UK market ($USD993.37K).
Compensation vs Earnings: Keith's compensation has been consistent with company performance over the past year.
Leadership Team
Experienced Management: CRW's management team is seasoned and experienced (10.8 years average tenure).
Board Members
Experienced Board: CRW's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: CRW insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 34.3%.
Top Shareholders
Company Information
Craneware plc's employee growth, exchange listings and data sources
Key Information
- Name: Craneware plc
- Ticker: CRW
- Exchange: AIM
- Founded: 1999
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: UK£813.558m
- Shares outstanding: 35.53m
- Website: https://public.craneware.com
Number of Employees
Location
- Craneware plc
- 1 Tanfield
- Edinburgh
- EH3 5DA
- United Kingdom
Listings
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/10/26 17:48 |
| End of Day Share Price | 2021/10/26 00:00 |
| Earnings | 2021/06/30 |
| Annual Earnings | 2021/06/30 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.